Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China
· Delayed Price · Currency is CNY 5.41
-0.01 (-0.18%)
At close: Mar 10, 2026
SHE:002872 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -96.39 | -87.4 | -93.07 | -90.56 | -67.81 | -490.73 | Upgrade
|
| Depreciation & Amortization | 107.06 | 107.06 | 107.26 | 107.72 | 89.99 | 117.05 | Upgrade
|
| Other Amortization | 5.84 | 5.84 | 2.83 | 2.76 | 3.25 | 4.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0.23 | -9.53 | -5.22 | 20.97 | Upgrade
|
| Asset Writedown & Restructuring Costs | 24.18 | 24.18 | 4.81 | 3.21 | 8.48 | 367.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | -16.56 | -16.56 | -2.01 | -4.92 | -4.57 | 2.57 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.78 | -0.78 | 4.24 | 1.27 | 17.58 | -4.45 | Upgrade
|
| Other Operating Activities | 51.41 | 43.86 | 29.45 | 31.88 | 10.6 | 55.23 | Upgrade
|
| Change in Accounts Receivable | 15.65 | 15.65 | 103.03 | 54.68 | -419.09 | 277.36 | Upgrade
|
| Change in Inventory | 28.03 | 28.03 | 49.47 | -6.86 | 167.57 | -3.69 | Upgrade
|
| Change in Accounts Payable | -61.96 | -61.96 | -231.1 | -4.71 | 187.8 | -112.93 | Upgrade
|
| Change in Other Net Operating Assets | 2.09 | 2.09 | 2.16 | - | - | - | Upgrade
|
| Operating Cash Flow | 48.71 | 50.15 | -24.56 | 89.18 | 18.97 | 189.75 | Upgrade
|
| Operating Cash Flow Growth | -20.87% | - | - | 370.09% | -90.00% | 31.06% | Upgrade
|
| Capital Expenditures | -16.78 | -50.27 | -76.74 | -73.42 | -114.38 | -92.7 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.29 | 0.09 | 15.05 | 14.88 | 36.34 | 7.62 | Upgrade
|
| Cash Acquisitions | - | - | -30 | - | -29.4 | 2.59 | Upgrade
|
| Divestitures | -19.54 | - | - | 22.45 | 31.08 | 7.1 | Upgrade
|
| Investment in Securities | 29.58 | 30 | - | 82 | -72.7 | -2 | Upgrade
|
| Other Investing Activities | -4.82 | 25.75 | 156.6 | 6.12 | 318.64 | 1.24 | Upgrade
|
| Investing Cash Flow | -7.27 | 5.57 | -82.08 | -65.57 | 169.58 | -76.15 | Upgrade
|
| Long-Term Debt Issued | - | 282.5 | 213.3 | 101 | 226.74 | 600.79 | Upgrade
|
| Long-Term Debt Repaid | - | -221.85 | -208.97 | -167.53 | -358.33 | -728.16 | Upgrade
|
| Net Debt Issued (Repaid) | -0.01 | 60.65 | 4.33 | -66.53 | -131.59 | -127.37 | Upgrade
|
| Issuance of Common Stock | 5.2 | 5.2 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -14.66 | -15.26 | -15.54 | -15.94 | -22.89 | -37.19 | Upgrade
|
| Other Financing Activities | 3.66 | -0.04 | - | 38 | 15.51 | 29.99 | Upgrade
|
| Financing Cash Flow | -5.8 | 50.56 | -11.2 | -44.47 | -138.97 | -134.57 | Upgrade
|
| Net Cash Flow | 35.64 | 106.27 | -117.85 | -20.85 | 49.58 | -20.97 | Upgrade
|
| Free Cash Flow | 31.94 | -0.13 | -101.3 | 15.76 | -95.41 | 97.05 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 88.30% | Upgrade
|
| Free Cash Flow Margin | 6.19% | -0.02% | -17.49% | 2.60% | -12.95% | 8.07% | Upgrade
|
| Free Cash Flow Per Share | 0.10 | - | -0.32 | 0.05 | -0.30 | 0.30 | Upgrade
|
| Cash Income Tax Paid | 44.24 | 48.51 | 60.49 | 22.19 | 24.21 | 27.41 | Upgrade
|
| Levered Free Cash Flow | 146.43 | 57.93 | -57.8 | -37.29 | 171.75 | 186.55 | Upgrade
|
| Unlevered Free Cash Flow | 155.21 | 67.17 | -48.43 | -27.43 | 186.97 | 210.85 | Upgrade
|
| Change in Working Capital | -26 | -26 | -77.84 | 47.35 | -33.34 | 116.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.